Efficacy-Based Perspective to Overcome Reduced Opioid Analgesia of Advanced Painful Diabetic Neuropathy in Rats
In conclusion, the reduction in the analgesic action of opioids in DNP might be a consequence of MOR reduction, particularly in the spinal cord. Therefore, developing opioids of high efficacy might provide analgesia exceeding that of currently available opioids. Introduction Neuropathic pain (NP) is a chronic pain condition that limits patients to fully achieve their daily tasks. Consequently, NP has significant impact on the economic welfare of the society (Bouhassira et al., 2008; Gaskin and Richard, 2012). Therefore, to find drugs satisfactorily treating NP is a major clinical goal. The management of severe acute to moderate pain including cancer pain can be achieved by opioids, however, opioid effectiveness in the treatment of chronic NP is controversial (Wiffen et al., 1996; Eriksen et al., 2006; Furlan et al., 2006; Derry et al., 2016; Hoffman et al., 2017). At present, opioids are considered as a second-to-third-line medication for NP. However, they can be considered as first line drugs, when they may offer advantages over the general first line drugs for instance in case of cancer NP, an acute pain attack or during first line drug titration. Data from in vivo experimental studies have reported on a significant reduction in opioid antinociceptive efficacy in neuropathic animals following systemic administration (Courteix et al., 1998; Hama and Sagen, 2007). The loss in opioid antinociceptive efficacy has also been reported following central (spinal or supraspin...
Publication date: Available online 20 November 2019Source: Journal of Advanced ResearchAuthor(s): Sohail Mumtaz, Pradeep Bhartiya, Neha Kaushik, Manish Adhikari, Pradeep Lamichhane, Su-Jae Lee, Nagendra Kumar Kaushik, Eun Ha ChoiAbstractOver the past few decades, microwave (MW) radiation has been widely used, and its biological effects have been extensively investigated. However, the effect of MW radiation on human skin biology is not well understood. We study the effects of pulsed high-power microwaves (HPMs) on melanoma (G361 and SK-Mel-31) and normal human dermal fibroblast (NHDF) cells. A pulsed power generator (Chundo...
We are pleased to invite investors and analysts to participate in a live audio webcast and conference call on Monday, 16 December 2019, highlighting Roche data presented at the San Antonio Breast Cancer Symposium in San Antonio, Texas, from 10th - 14th December.
Journal of Medicinal Food, Ahead of Print.
Journal of Medicinal Food, Ahead of Print.
Are patients with mental health conditions or lower socioeconomic status more likely to receive long-term opioid therapy?Pain
Artificial intelligence is already widely entrenched in healthcare industry, so the question should not be, "Will AI happen or not?"Â said David Houlding, CISSP, CIPP, principal healthcare lead, at Microsoft,Â in an interview with MD+DI. âIt's very much 'What tasks will AI help with, and what will it do and what will it not do?â â he continued. âI think we're still learning some of that, but it's largely a proven technology, not just for healthcare providers but for payers, for pharmaceuticals, for life sciencesâ...
CONCLUSIONS Our data demonstrate an oncogenic role of miR-652 in uveal melanoma, showing that miR-652 may be a useful biomarker for prediction of prognosis for patients with uveal melanoma. PMID: 31740654 [PubMed - in process]
CONCLUSIONS Early detection of SB CD without complications remains difficult even if advanced modalities are introduced. Our hypothesis is that the fecal occult blood test and routine blood test should be administered to patients with abdominal pain or gastrointestinal manifestations. Once the patients are found to have GI bleeding or anemia, they would be further examined according to the guideline and SBCE would be used in the early stage of SB CD. PMID: 31738744 [PubMed - in process]
CONCLUSIONS The nude mouse orthotopic liver transplantation model of human HCC was shown to be a reliable model that has the potential for future research on the pathogenesis and progression of HCC and studies on drug development. PMID: 31736477 [PubMed - in process]
CONCLUSIONS Our findings suggest that PLR is a useful parameter to consider when hematologists attempt to assess the risk of recurrence in ITP patients receiving first-line therapy, and the nonlinearity of PLR and ITP recurrence risk must be fully considered when constructing predictive models. PMID: 31735908 [PubMed - in process]
More News: Academies | Anesthesia | Anesthesiology | Back Pain | Biochemistry | Blindness | Brain | Brain Cancers | Calcium | Canada Health | Cancer | Cancer & Oncology | Chemistry | Chronic Pain | Clonidine | Databases & Libraries | Depression | Diabetes | Diabetes Type 1 | Drugs & Pharmacology | Endocrinology | Epidemiology | Eyes | Fentanyl | Ganglions | Gastric (Stomach) Cancer | Gastroenterology | Germany Health | Grants | Hungary Health | Intensive Care | Italy Health | Medical Ethics | Men | Morphine | Neurology | Opthalmology | Pain | Pain Management | Perfusion | PET Scan | Respiratory Medicine | Statistics | Students | Study | Switzerland Health | Tramadol | Universities & Medical Training | USA Health